This is the authors' abstract. We don't add key points for this paper.
Chemical exposure causes adverse neurological outcomes, highlighting the need for high-throughput screening of chemical neurotoxicity. However, existing computational methods rely on single-modality inputs and lack complementary molecular information to sufficiently enhance the accuracy and efficiency of neurotoxicity risk assessment. Here, we present NeuroToxPredictor, a scalable and interpretable multimodal framework built on a curated chemical neurotoxicity dataset for accurate and efficient chemical neurotoxicity prediction. It integrates graph attention networks and molecular fingerprints with ChemBERTa, a pretrained chemical language model that provides contextual encoding of SMILES. A gated fusion module adaptively weights these complementary representations according to their predictive relevance to enhance modality-specific weight allocation through a gating fusion mechanism. NeuroToxPredictor achieved competitive performance across five independent training seeds (AUC = 0.919 ± 0.004; accuracy = 0.845 ± 0.014; F1-score = 0.861 ± 0.011; recall = 0.884 ± 0.013; precision = 0.839 ± 0.024; MCC = 0.688 ± 0.028), outperforming both single-modality and reduced-modality baselines. It demonstrates strong generalizability with an AUC of 0.861, as externally validated on an independent set of 279 compounds. NeuroToxPredictor is deployed on a publicly platform (https://www.ai4environ.cn/NeuroToxPredictor), enabling an end-to-end intelligent workflow from chemical retrieval, neurotoxicity prediction, applicability-domain assessment, and large language model-assisted result interpretation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: